Member Info for Natdan

One hopes he will not see his role as a mercenary, to be parachuted into some of the more ‘exotic’ nations where the company have certain ‘contracts’ of uncertain value, to rescue floundering revenues.
It Ain’t Half Hot Mum....

“ I take the macro view” twix gems in abundance today. So no micro-managing of each and every SP movement.
Or try this one..” If I had a crystal ball I would know what and when,but as I don't....”
Peppered with the usual dyslexia and an abusive manner developed in a mother’s back-bedroom on Twitterati, this just has to be the most despicable specimen on any forum.
Just 3 million bogus to offload now...

“ I seek to reduce but not averse to buying oops along the way ”
Seems you have had a few buying oops along the way, you’ve got 3 million to offload, oh honest sage!
Not surprised you would take 20p. There’s only so long you can snorkel underwater before you drown?

Davand, thanks for the clarification.

I do not wish to appear overly negative, and readily admit to a lack of understanding of the logistics of the latest announcement.
But, if the product being launched was a part of Coastal Genomics when acquired in august 2020, why has it taken until November 2021 to demonstrate it and start to bring it to market? Surely covid cannot be a valid explanation? Or was it still being developed? Who knows? And what is its potential, etc?
Also, “ Yourgene will also be sponsoring a virtual booth at the event” does have a cheap feel to it.
What happened to hard-faced sales staff securing orders, or is that not yet the intention here?

Whilst appreciating LR may be taking on board investors’ wishes of greater updates as to the company’s activities, it would be appreciated to receive the rationale of this exhibition to the hard of understanding, like moi.

The selling is continual and relentless. I wonder which II is packing their bags and leaving at whatever cost? I must confess I never viewed the trading update as a profit warning.
Hopefully new blood will begin to buy in at these prices?

Davand, the timing of your comment was exquisite! Right on cue..

Good to see the Takeover Panel intervention in thursday’s rns.
The cloak-and-dagger antics from Marks have gone on for far too long: he either wants to sell the company or he doesn’t. Lest we forget, this company is a bombed-out tiddler, not a high-street prospering giant.
To both parties: Either agree a firm bid price and sell, or stop being a time waster.

Good to see that the wisdom of our residential Sage never ceases to illuminate and inspire.
Is this the same ‘crash’ which he had nailed on in the last quarter 2020/ early 2021? Flexibility is the name of the game. This time next year....seems to be a veritable crash-test dummy.
As for the dubious 3 million holding, how to get rid in an orderly fashion whilst predicting doom on the horizon? Holds Ygen allegedly but has never evidenced a diverse portfolio. Strange.
Reverting to his characteristic abuse is indicative of a lonely individual who has honed his pitiful communication skills on Twitter.

Good to see twix has secured day-release, presumably supervised and with restraining strait-jacket on standby.
Would love to know how he will offload his 3million holding without being noticed!

I am trying my best to stay optimistic here. But as each moribund trading day passes, the question as to why does this company remain quoted becomes ever louder? Is it financially beneficial to remain on Aim? At an estimated cost of 400 to 600k a year, it appears not. Is the company regularly raising funds from the market to, for example, fund expansion? No. Has the listing boosted the company’s public profile since inception? I doubt many outside the specialist field here have took an interest? Have any of the truly large IIs built up a substantial holding? No. Is there an efficient market in this share in terms of active trading? Most certainly not! Are LR’s and BH’s aspirations of a 500 mkt cap and vague murmurs of a Nasdaq listing anywhere near achievable? Pass.

It seems evident that the IIs who have summoned LR and AR to London have caused a short-term paralysis in the trading of this share. One can only hope for positive noises from the outcome when the toes of LR and AR have been held to the fire. An indefinite suspension of any further dilution of the shares in existence would be a positive signal. Perhaps even AR (nice, dapper city-geezer notwithstanding) disappearing into the sunset, to be replaced by a chair with specialist and proven knowledge in this field, might also be welcome.

If one recalls, the original pandemic panic focused on trying to ensure the nhs was not overwhelmed by a virus with then unknown capabilities. Since then, mass vaccination especially for those vulnerable that most needed protecting, and herd immunity (despite denials) surpassed.
The whole testing regime has been a £37 billion unmitigated disaster, and the nhs cannot continually revert to its default position that it needs to be protected...from the public and not vice versa.
Frankly LR has yet to demonstrate a successful business strategy vis-a-vis covid testing, slow to read the tea-leaves, slow to make friends within the government and generally late to the party.
Would that he could now drive organic growth el rapido with the core business. With no further added dilution, of course.

The open letter from this Cooke bloke sounds like a CEO who has done well piggy-backing the nhs for the duration of covid via PCR testing suddenly having the rug pulled from under his lucrative feet.
Even the doomster in chief Whitty stated some time back that we have to live with covid, so scaling back PCR testing was really inevitable. The throwaway claim he makes that the nhs is hanging by a thread in terms of capacity doesn’t wash anymore.

With regard to Ygen it seems the SP will remain comatose until we too wean ourselves off the covid obsession and demonstrate as a company that its other promising products have traction.
The longer these shy US blue-chips, for example,decline to step from behind the door, reveal their identity and show us all the size of their package, the more this has a feel of Cilla’s ‘Blind Date.’
Let’s hope this contractual episode doesn’t end with a ‘surprise, surprise!.’

The reasons for listing on the stock market are wide and varied. Listing on aim is inherently a riskier call.
The longer this share remains becalmed and the less it is traded, the harder it is to justify the expense of remaining a plc.
One can trot out the usual reasons for seeking a listing, such as the requirement to raise capital, creating a heightened profile or even the ability to attract board members of a high calibre (although in this case the contribution of individual members of a disproportionately large BOD is opaque on occasion).
Less talked about, until now, is the self-rewarding and mutual back-slapping of the directors utilising the various share instruments available to them.
One can only hope that whichever IIs have expressed concern over the share performance of this company to date and the significant dilution which has resulted, focus may shift to a period of good old-fashioned organic growth.
The company appears to have launched a decent number of products, has an impressive geographical spread, but now needs to drive the growth so that the SP reflects the true value of this company.

Well, well, well. One of the last long-time rag-traders has finally thrown in the towel. Sold for a rag-price. He should have listened to the sirens years ago...

GLT/ Ron.
Yes it seems it is Doctor Institutional who is determined to dispense the medication -moderation to curb growing management obesity.

Doctor, this share has zero pulse presently. Major surgery is required: the consultants in the form of the IIs have summoned the junior doctors-the BOD- to a reassessment of their dietary habits and requirements.
It seems far too many options and similar diluting morsels are being handed around and being gorged on by management who appear to be growing fat on such largesse, resulting in a permanently pallid share price and an absence of any financial health benefit for the loyal shareholders.
Hopefully any corrective surgery administered will have a positive health reward for all and not just the few. Who knew?

I am a little curious as to AR’s standing within the Co. as a result of today’s manoeuvres.
Personable chap that he is in the traditional city “wide-boy” image, call me old-fashioned but I find it unprofessional for a chairman to attend a formal agm without troubling to wear a tie!.
That said, I found it unsettling that a massive 90 million proxy votes were registered against re-electing him as a director, against 150 million for. This is not your ordinary share-holder expressing discontent, this must be the Institutions, and it does not feel like a vote of confidence.
And so it came to pass, that a mere one hour before the start of the agm the proverbial curly finger was exercised, summoning our leaders to the capital for further discussion.
I do love the gloss put on the explanatory rns, “ This decision was made following dialogue with institutional shareholders and demonstrates the Board's willingness to consider feedback and act accordingly.”
I get the impression patience is wearing thin with some of the IIs and the moribund SP performance.
I wonder whether AR’s position may come under some pressure near-term. Or I may be barking up the wrong tree?

Very encouraging bounce back and improvement in the business.
However, am wondering about:-
“ Our long-term strategy remains to build an international molecular diagnostics business of scale, and we have plans to redeploy COVID-generated funds into further enhancing our core Genomic Service and Genomic Technology business streams.”
Seems to be an early signal for further acquisitions in the future? it’s certainly LR’s MO in his previous business life. If so, buy wisely dear chap, preferably without tapping the market.

How do you get it so wrong that you purchased 3 million of the rascals ( of course you did) over at least 6 years, desperately trying to average down and dressing it up as inspirational purchases?
And then trying to offload with the tiniest of sales whilst predicting a market crash today, tomorrow, next week?
All the while spouting negativity against the company and its management.
My, how that psychosis takes hold when left untreated: all investors are fools, don’t you know, for not heeding the wisdom of the sage.